![](https://insights-api.jefferies.com/wp-content/uploads/2024/02/Sleep-Apnea.jpg?w=3840&q=75)
Shifting Tides in the Sleep Apnea Treatment Market: From Philips’ Re-Entry to Ozempic
Jefferies unpacks the latest trends in pricing, product quality, and novel therapeutic approaches that are shaping an eventful 2024 for the sleep apnea treatment market.
![](https://insights-api.jefferies.com/wp-content/uploads/2023/12/national-cancer-institute-XknuBmnjbKg-unsplash.jpg?w=3840&q=75)
Balancing Act: Navigating Conflicting ESG Challenges in Healthcare
For healthcare companies, balancing ESG concerns with an affordable and robust supply chain is a constant challenge. How do today’s healthcare leaders approach this balancing act?
![](https://insights-api.jefferies.com/wp-content/uploads/2023/09/Person-on-Scale.jpg?w=3840&q=75)
Weigh to Go: Assessing the Wider Implications of a Slimmer Society
Jefferies’ Global Research teams detail the possible implications for a slimmer consumer, with sticky behavioral changes, across 7 sectors. They identify ~80 companies that could benefit and ~80 that may find this a structural headwind.